Cell replacement therapy is the remedial solution for treating Parkinson's disease.

@article{Dhivya2017CellRT,
  title={Cell replacement therapy is the remedial solution for treating Parkinson's disease.},
  author={Venkatesan Dhivya and Vellingiri Balachandar},
  journal={Stem cell investigation},
  year={2017},
  volume={4},
  pages={59}
}
The selective degeneration of dopaminergic (DA) neurons in Parkinson's disease (PD) has made an idol target for cell replacement therapies and other emerging surgical treatments. Certainly, by transplantation method, the therapeutic regimens such as human fetal ventral midbrain (hfVM) cells, human embryonic stem cells (hESCs), human neural stem/precursor/ progenitor cells (hNSCs/hNPCs), human mesenchymal stem cells (hMSCs), human induced neural stem cells (hiNSCs), and human induced pluripotent… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 3 times over the past 90 days. VIEW TWEETS